The American Association for Cancer Research (AACR) was once again the beneficiary of the annual Party with a Purpose fundraiser, with over 450 guests attending the event this fall. Dan and Sarah Keating received the Humanitarian Award for their dedication to cancer research. Dr. Stephen Rubin, of Fox Chase Cancer Center, was awarded the Scientific Achievement Award. Nydia Han, a newscaster with TV station 6abc, served as emcee. Beverly Goldberg, co-chair of the gala, announced that funds raised this year would go toward the research and treatment of ovarian cancer.
At a dedication prior to the Party with a Purpose event, honoree Dan Keating explained the personal reasons for his commitment to the fight against cancer:
Seventeen years ago, I was diagnosed with non-Hodgkin lymphoma. Had it not been for the discovery of Rituxan, I just would not be here today. When I went into remission, I made a promise with myself to one, be a better person; two, never take one day on earth with my family for granted; and three, give back to cancer-fighting organizations.
Among the attendees at the Party with a Purpose gala was Dr. John Glick of Penn Medicine’s Abramson Cancer Center. The Keatings credit Dr. Glick with having treated Dan Keating successfully for cancer.
The AACR is the first and largest cancer research organization in the world. The Philadelphia-based nonprofit organization was founded in 1907 by a group of 11 physicians and scientists interested in research “to further the investigation and spread the knowledge of cancer.”
The mission of the AACR is to understand, prevent, diagnose, treat and cure cancer by promoting research, education, communication and collaboration. To that end, the AACR focuses on every facet of high-quality, innovative cancer research.
The AACR gives direct grants for basic, translational, clinical and population research, targeting innovative science that has the potential to have a major impact in the fight against cancer. Additionally, the AACR provides expert peer review, grants administration and scientific oversight of team science and individual grants in cancer research that hold the promise of near-term patient benefit.
The organization’s reputation for scientific breadth and excellence attracts the premier researchers in the field, helping to make the AACR the authoritative source of information about advances in the causes, detection, diagnosis, treatment and prevention of the more than 200 diseases we call cancer.
Photos by Bonnie Squires.